| Non-invasive biomarkers for early detection of breast cancer J Li, X Guan, Z Fan, LM Ching, Y Li, X Wang, WM Cao, DX Liu Cancers 12 (10), 2767, 2020 | 150 | 2020 |
| The therapeutic potential of targeting ABC transporters to combat multi-drug resistance P Bugde, R Biswas, F Merien, J Lu, DX Liu, M Chen, S Zhou, Y Li Expert opinion on therapeutic targets 21 (5), 511-530, 2017 | 128 | 2017 |
| Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2) KW Tan, Y Li, JW Paxton, NP Birch, A Scheepens Food chemistry 138 (4), 2267-2274, 2013 | 111 | 2013 |
| Concentration-dependent effect of naringin on intestinal absorption of β1-adrenoceptor antagonist talinolol mediated by P-glycoprotein and organic anion transporting … Y Shirasaka, Y Li, Y Shibue, E Kuraoka, H Spahn-Langguth, Y Kato, ... Pharmaceutical research 26 (3), 560-567, 2009 | 98 | 2009 |
| Extracts from New Zealand Undaria pinnatifida Containing Fucoxanthin as Potential Functional Biomaterials against Cancer in Vitro. SK Wang, Y Li, WL White, J Lu J Funct Biomater 5 (2), 29-42, 2014 | 75 | 2014 |
| Anti-proliferation potential and content of fucoidan extracted from sporophyll of New Zealand Undaria pinnatifida W Mak, SK Wang, T Liu, N Hamid, Y Li, J Lu, WL White Frontiers in nutrition 1, 9, 2014 | 73 | 2014 |
| Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells Y Li, JL Revalde, G Reid, JW Paxton Cancer chemotherapy and pharmacology 68 (3), 603-610, 2011 | 72 | 2011 |
| The GDNF Family: A Role in Cancer? GC Fielder, TWS Yang, M Razdan, Y Li, J Lu, JK Perry, PE Lobie, DX Liu Neoplasia 20 (1), 99-117, 2018 | 68 | 2018 |
| Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells H Xu, J Paxton, J Lim, Y Li, W Zhang, L Duxfield, Z Wu Pharmaceutical research 31 (10), 2583-2592, 2014 | 64 | 2014 |
| Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer Y Li, JL Revalde, G Reid, JW Paxton Drug metabolism reviews 42 (4), 590-611, 2010 | 63 | 2010 |
| The effects of dietary and herbal phytochemicals on drug transporters Y Li, J Revalde, JW Paxton Advanced drug delivery reviews 116, 45-62, 2017 | 59 | 2017 |
| Dietary polyacetylenes of the falcarinol type are inhibitors of breast cancer resistance protein (BCRP/ABCG2) KW Tan, DP Killeen, Y Li, JW Paxton, NP Birch, A Scheepens European Journal of Pharmacology 723, 346-352, 2014 | 57 | 2014 |
| The effect of flavonoids on the ABC transporters: Consequences for flavonoid-drug interactions. Y LI, JW Paxton Expert Opinion on Drug Metabolism and Toxicology 9 (3), 267-85, 2013 | 50* | 2013 |
| Development of a gradient high performance liquid chromatography assay for simultaneous analysis of hydrophilic gemcitabine and lipophilic curcumin using a central composite … H Xu, J Paxton, J Lim, Y Li, W Z. J Pharm Biomed Anal. 98, 371-8, 2014 | 44 | 2014 |
| The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics Y Li, J Lu, J W Paxton Current drug metabolism 13 (5), 624-639, 2012 | 44 | 2012 |
| Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles K Myint, Y Li, JW Paxton, MJ McKeage PLOS One 10 (7), 2015 | 42 | 2015 |
| Hop-derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein (BCRP/ABCG2). KW Tan, J Cooney, D Jensen, Y Li, P JW, B NP, S A. Mol Nutr Food Res., 2014 | 42 | 2014 |
| Pleiotropic roles of ABC transporters in breast cancer J He, E Fortinatu, DX Liu, Y Li International Journal of Molecular Sciences 22 (6), 1-24, 2021 | 41 | 2021 |
| Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance J Revalde, Y Li, B Hawkins, R Rosengren, J Paxton Biochemical Pharmacology, 2014 | 34 | 2014 |
| HTRA3 is reduced in ovarian cancers regardless of stage M Zhao, JX Ding, GY Nie, J Wei, Y Li, XY Yin, Q Chen Cancer investigation 32 (9), 464-469, 2014 | 31 | 2014 |
Professor Jun LuAuckland Bioengineering Institute, University of AucklandVerified email at auckland.ac.nz
